BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Feb 21, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-02-19

Reporting Person: MEIER RICHARD A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-19	Common Stock	M	5000	$16.92	Acquired	23650	Direct
2013-02-19	Common Stock	S	5000	$57.5	Disposed	18650	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-19	Stock Option (right to buy)	$16.92	M	5000	Disposed	2016-12-13	Common Stock (5000)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on December 11, 2012.

F2: Options vest 1/4th each on March 14, 2007, June 14, 2007, September 14, 2007 and December 14, 2007.